BG103881A - Method for the preparation of elurbiprophene pastills - Google Patents

Method for the preparation of elurbiprophene pastills

Info

Publication number
BG103881A
BG103881A BG103881A BG10388199A BG103881A BG 103881 A BG103881 A BG 103881A BG 103881 A BG103881 A BG 103881A BG 10388199 A BG10388199 A BG 10388199A BG 103881 A BG103881 A BG 103881A
Authority
BG
Bulgaria
Prior art keywords
pastills
preparation
mixture
elurbiprophene
pastill
Prior art date
Application number
BG103881A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Day
Huw Jones
Carl Smith
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG103881A publication Critical patent/BG103881A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG103881A 1997-05-22 1999-11-15 Method for the preparation of elurbiprophene pastills BG103881A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (1)

Publication Number Publication Date
BG103881A true BG103881A (en) 2000-05-31

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103881A BG103881A (en) 1997-05-22 1999-11-15 Method for the preparation of elurbiprophene pastills

Country Status (31)

Country Link
US (1) US6194003B1 (ko)
EP (1) EP0983059B1 (ko)
JP (1) JP2001527567A (ko)
KR (1) KR20010012739A (ko)
CN (1) CN1154480C (ko)
AR (1) AR015812A1 (ko)
AT (1) ATE245021T1 (ko)
AU (1) AU725760B2 (ko)
BG (1) BG103881A (ko)
BR (1) BR9809651A (ko)
CA (1) CA2290830C (ko)
CZ (1) CZ290816B6 (ko)
DE (1) DE69816440T2 (ko)
DK (1) DK0983059T3 (ko)
ES (1) ES2202871T3 (ko)
GB (1) GB9710521D0 (ko)
HU (1) HU224954B1 (ko)
ID (1) ID22949A (ko)
IL (1) IL132999A0 (ko)
IN (1) IN187837B (ko)
MY (1) MY118410A (ko)
NO (1) NO995681D0 (ko)
NZ (1) NZ500664A (ko)
PL (1) PL190947B1 (ko)
PT (1) PT983059E (ko)
RU (1) RU2203046C2 (ko)
SK (1) SK283701B6 (ko)
TR (1) TR199902725T2 (ko)
UA (1) UA53714C2 (ko)
WO (1) WO1998052539A1 (ko)
ZA (1) ZA984260B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263510T3 (es) 1999-12-09 2006-12-16 Reckitt Benckiser Healthcare (Uk) Limited Preparacion en comprimidos que comprende un antiinflamatorio no esteroideo (aine).
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
US20050252144A1 (en) * 2004-04-29 2005-11-17 Macdonald Robert A Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CN103479582A (zh) 2005-02-03 2014-01-01 武田奈科明有限公司 制备含钙组合物的快速湿聚结方法
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
KR20100020449A (ko) * 2007-07-23 2010-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 기호적으로 허용될 수 있는 인돌 세로토닌 수용체 작용제 경구 투여 제제 및 이를 사용하는 방법
MY155652A (en) * 2008-08-22 2015-11-13 Reckitt Benckiser Healthcare Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
PL2701681T3 (pl) 2011-04-29 2017-03-31 Moberg Pharma Ab Kompozycje farmaceutyczne zawierające środek miejscowo znieczulający, taki jak bupiwakaina, do podawania miejscowego do jamy ustnej lub gardła
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Pharma Seeds Create NSAIDsまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
PL190947B1 (pl) 2006-02-28
AU7916598A (en) 1998-12-11
PT983059E (pt) 2003-11-28
KR20010012739A (ko) 2001-02-26
HUP0002121A3 (en) 2001-04-28
TR199902725T2 (xx) 2000-02-21
SK283701B6 (sk) 2003-12-02
EP0983059A1 (en) 2000-03-08
NO995681L (no) 1999-11-19
JP2001527567A (ja) 2001-12-25
BR9809651A (pt) 2000-07-11
UA53714C2 (uk) 2003-02-17
HUP0002121A2 (hu) 2000-12-28
EP0983059B1 (en) 2003-07-16
CZ290816B6 (cs) 2002-10-16
SK158899A3 (en) 2000-05-16
US6194003B1 (en) 2001-02-27
AU725760B2 (en) 2000-10-19
AR015812A1 (es) 2001-05-30
NZ500664A (en) 2001-01-26
GB9710521D0 (en) 1997-07-16
WO1998052539A1 (en) 1998-11-26
DE69816440T2 (de) 2004-05-13
CN1154480C (zh) 2004-06-23
IL132999A0 (en) 2001-03-19
CA2290830A1 (en) 1998-11-26
IN187837B (ko) 2002-06-29
CN1255848A (zh) 2000-06-07
ATE245021T1 (de) 2003-08-15
RU2203046C2 (ru) 2003-04-27
CZ412099A3 (cs) 2000-02-16
DK0983059T3 (da) 2003-11-03
NO995681D0 (no) 1999-11-19
PL336624A1 (en) 2000-07-03
ID22949A (id) 1999-12-16
ES2202871T3 (es) 2004-04-01
DE69816440D1 (de) 2003-08-21
ZA984260B (en) 1999-02-20
MY118410A (en) 2004-10-30
CA2290830C (en) 2006-07-11
HU224954B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
BG103881A (en) Method for the preparation of elurbiprophene pastills
DE69216642D1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
CA2335179A1 (en) Tablet and process for making the same
EP0904781A3 (en) Improved pharmaceutical composition comprising fenofibrate
DE69123075D1 (de) Ueberzogene Zusammensetzung sowie Verfahren zu ihrer Herstellung
ES8602599A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminoxiclohexil-amida.
HUT37418A (en) Process for producing new 2,2&#39;-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
ES8607914A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminociclohexil-amida.
IL112957A0 (en) Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
HUT40918A (en) Process for producing new galenic compositions with retard dissolution of the active agents
IE870112L (en) Fused benzazepines and intermediates thereof
IT8421821V0 (it) Struttura di blocco di iniezione per l&#39;alimentazione di stampi con materiale termoplatisco fuso.
HUP0004588A3 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments and pharmaceutical compositions containing them
AU7095687A (en) Pellet-containing pharmaceutical compositions
TW350773B (en) Melted granulated preparation of sucralfate for the treatment of digestic ulcer and its manufacturing method thereof
MX9705834A (es) Nueva composicion farmaceutica que contiene trimebutina y proceso para su preparacion.
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
DE3265210D1 (en) Novel compounds with antiinflammatory and analgesic activity, process for the preparation thereof and pharmaceutical compositions therefrom
GR3001800T3 (en) 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime derivative, process for the production thereof, pharmaceutical composition and intermediates
FR2769839B1 (fr) Composition anhydre a base de lactulose
IL86031A (en) Substituted thiophene compounds,their production and pharmaceutical compositions containing them
HUT40648A (en) Process for producing optically active substituted 1,4-dihydro-pyridines and pharmaceutical compositions containing them as active agents
IL74388A (en) 2,3,4,5-tetrahydro-11-phenyl-1h-(1,4)diazepino(1,7-a)indoles,their production and pharmaceutical compositions containing them
HUT58068A (en) Process for producing new, pharmacologically active compounds and pharmaceutical composition comprising same as acvtive ingredient
NZ287916A (en) Incorporating unipolar charge into particles, charge injected into molten material prior to formation of particles